Morgan Stanley raises Ryan Specialty target to $42
Morgan Stanley analyst Bob Huang maintained an Overweight rating on Ryan Specialty Holdings and raised the price target to $42 from $39. Separately, Goldman Sachs analyst Robert Cox maintained a Neutral rating with a price target of $40, up from $35.
*this image is generated using AI for illustrative purposes only.
Morgan Stanley analyst Bob Huang has maintained an Overweight rating on Ryan Specialty Holdings while raising the price target to $42 from $39. This revised target reflects an updated valuation for the NYSE-listed specialty insurance firm. Separately, Goldman Sachs analyst Robert Cox maintained a Neutral rating on the stock with a price target of $40, up from a previous $35.
Rating and Price Action
The research note from Morgan Stanley reaffirms the Overweight stance, suggesting the stock offers potential upside relative to its sector peers. The price target increase to $42 implies confidence in the firm's fundamentals and market conditions.
| Firm | Analyst | Rating | Previous Price Target | New Price Target |
|---|---|---|---|---|
| Morgan Stanley | Bob Huang | Overweight | $39 | $42 |
| Goldman Sachs | Robert Cox | Neutral | $35 | $40 |
Ryan Specialty Holdings trades under the ticker symbol RYAN.
What specific factors are driving the improved valuation for Ryan Specialty Holdings?
How might the divergence between Morgan Stanley's Overweight and Goldman Sachs' Neutral ratings impact investor sentiment?
What upcoming earnings or market events could further influence the stock's performance?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
